Wendy Dixon

Wendy Dixon

Director/Board Member at ARVINAS, INC.

Net worth: 569 449 $ as of 2024-03-30

68 year
Health Technology
Consumer Services
Finance

Profile

Wendy L.
Dixon
currently works at Alkermes, Inc., as Independent Director from 2011, Zevra Therapeutics, Inc., as Independent Director from 2023, Arvinas, Inc., as Independent Director from 2020, Special Equestrians, Inc., as Director, and Great Meadow Consulting LLC, as President from 2009.
Dr. Dixon also formerly worked at Sesen Bio, Inc., as Chairman from 2016 to 2020, DENTSPLY International, Inc., as Director from 2005 to 2010, Incyte Corp., as Independent Director from 2011 to 2022, Orexigen Therapeutics, Inc., as Independent Director from 2010 to 2016, Furiex Pharmaceuticals, Inc., as Independent Director from 2012 to 2014, bluebird bio, Inc., as Independent Director from 2013 to 2021, Ardea Biosciences, Inc., as Director in 2011, Edimer Pharmaceuticals, Inc., as Director, Iovance Biotherapeutics, Inc., as Independent Director from 2022 to 2023, Alkermes Plc, as Independent Director from 2011 to 2022, Voyager Therapeutics, Inc., as Independent Director from 2017 to 2021, Black Diamond Therapeutics, Inc., as Independent Director from 2022 to 2024, Bristol Myers Squibb Co., as Chief Marketing Officer in 2009, Centocor, Inc., as Principal, Merck & Co., Inc., as Senior Vice President-Marketing USHH from 1996 to 2001, Osteotech, Inc., as Principal, West Pharmaceutical Services, Inc., as Principal, The Monitor Group, Inc., as Senior Advisor, and Smithkline & French Laboratories US, Inc., as Principal.
Dr. Dixon received her undergraduate degree, graduate degree, and doctorate degree from the University of Cambridge.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-14 9,121 ( 0.01% ) 376 515 $ 2024-03-30
2024-03-14 38,054 ( 0.07% ) 192 934 $ 2024-03-30
2024-03-21 0 ( -.--% ) - $ 2024-03-30
2023-04-13 0 ( -.--% ) - $ 2024-03-30

Wendy Dixon active positions

CompaniesPositionStart
ARVINAS, INC. Director/Board Member 2020-06-28
ZEVRA THERAPEUTICS, INC. Director/Board Member 2023-04-24
President 2009-06-30
Director/Board Member -
Director/Board Member 2011-09-15
All active positions of Wendy Dixon

Former positions of Wendy Dixon

CompaniesPositionEnd
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 2024-04-09
IOVANCE BIOTHERAPEUTICS, INC. Director/Board Member 2023-06-05
ALKERMES PLC Director/Board Member 2022-07-06
INCYTE CORPORATION Director/Board Member 2022-06-13
░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Wendy Dixon's experience

Training of Wendy Dixon

University of Cambridge Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wendy Dixon's experience

Connections

99

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies11
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

INCYTE CORPORATION

Health Technology

MERCK & CO., INC.

Health Technology

WEST PHARMACEUTICAL SERVICES, INC.

Health Technology

ZEVRA THERAPEUTICS, INC.

Health Technology

BLUEBIRD BIO, INC.

Health Technology

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

VOYAGER THERAPEUTICS, INC.

Health Technology

ARVINAS, INC.

Health Technology

BLACK DIAMOND THERAPEUTICS, INC.

Health Technology

ALKERMES PLC

Health Technology

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Smithkline & French Laboratories US, Inc.

Health Technology

Health Technology

Consumer Services

Commercial Services

See company connections